Gemphire Therapeutics (GEMP) Misses Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts GEMP Hot Sheet
Join SI Premium – FREE
Gemphire Therapeutics (NASDAQ: GEMP) reported Q3 EPS of ($0.56), $0.11 worse than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Gemphire Therapeutics (GEMP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Investing.com’s stocks of the week
- Baird Upgrades AGCO Corporation (AGCO) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
